Notably, p62 is currently the only accurate pathological marker used to identify C9‐ALS in UK clinical practice; although DPR proteins and C9orf72 RNA foci are pathological markers of C9‐ALS, they are not used in routine neuropathology practice. Here, C9 is linked to amyotrophic lateral sclerosis.